Atlas Trials

Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer

Clinical trial NCT00470067 · TERMINATED

Trial details

NCT number
NCT00470067
Sponsor
Roswell Park Cancer Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Endometrial Cancer
Start date
2007-02-01
Primary completion
2008-05-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.